| Nome |
# |
|
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, file 919996e3-9f9f-4871-aa74-d86686acdd30
|
35
|
|
Remission maintenance in ANCA-associated vasculitis: does one size fit all?, file 6589433f-76d8-49ab-bf08-d76c10487461
|
33
|
|
Autoreactive B Cells in ANCA-Associated Vasculitis, file e3835199-4e0d-72ef-e053-3705fe0ad821
|
25
|
|
Tocilizumab in patients with multisystem Erdheim-Chester disease, file f7bfed51-ca3d-4909-9bda-c8d32106144c
|
13
|
|
Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis, file 47506a60-8b9b-4a0c-a509-1964ed10b208
|
12
|
|
Drug induced exfoliative dermatitis: state of the art., file fe78577c-b30a-41ff-8b52-32721c2ee64f
|
12
|
|
Hospitalisation rates among patients with primary Sjögren's syndrome: a population-based study, 1995-2016, file 88275dd9-04e6-4772-ab41-599596c2f007
|
9
|
|
A second case of pericardial mesothelioma mimicking systemic lupus erythematosus in the literature in over 30 years: a case report, file f24d4875-133d-4805-a33a-9b4f7a21f6d8
|
9
|
|
Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests, file ca8623fc-d7e5-4a78-a052-8a2c3d350490
|
8
|
|
Histamine release positive test associates with disease remission in chronic spontaneous urticaria: a
proof-of-concept study, file 063518a5-817e-43f7-8e58-477d7972afd8
|
5
|
|
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer, file e3835198-da94-72ef-e053-3705fe0ad821
|
5
|
|
Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations, file 049edb8d-379f-4d8a-aaee-eeb152eb6e09
|
4
|
|
Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes, file 35fbb7b9-58e8-4a71-b148-dda8301e99c7
|
3
|
|
Orthopnea with platydeoxia secondary to prominent Eustachian valve, file 4d5a054d-d561-4006-a906-7e5b17b0b62c
|
3
|
|
Giant cell arteritis restricted to the limb arteries: An overlooked clinical entity, file 549419e2-0120-43bd-9adb-10e28250a0cc
|
3
|
|
Rituximab hypersensitivity in IgG4-related disease: successful desensitization in a patient with IgG4 rheumatoid factor, file 8410924a-1866-44d3-b866-c224b8060074
|
3
|
|
Predicting Disease Activity in Systemic Vasculitides: On the Hunt for Potential Candidates, file 94271326-deb4-4e17-ade3-03b4fe4b4251
|
3
|
|
The Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis, file 97fa1703-abd1-4194-ab06-9ce771c997d3
|
3
|
|
Clinical Characterization and Predictors of IOS-Defined Small-Airway Dysfunction in Asthma., file ae64dca9-bef6-4f26-820b-dd4900ad04a9
|
3
|
|
Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab, file fc307354-00f1-4560-915f-db8ee0d29c2c
|
3
|
|
BRAFV600E-mutation Is Invariably Present and Associated to Oncogene-Induced Senescence in Erdheim-Chester Disease, file 01ce052e-5c7b-42d2-9748-e0699828eae5
|
2
|
|
Hypertrophic Cardiomyopathy Secondary to Hepatitis C Virus-Related Vasculitis, file 10030572-4a5c-456b-b113-02409df8e838
|
2
|
|
Eosinophilic Granulomatosis With Polyangiitis: Clinical Predictors of Long-term Asthma Severity, file 111015bd-a1a1-4cfe-92e6-a029480fa6ae
|
2
|
|
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease., file 15968b28-8139-4ff4-b115-777bd8acd891
|
2
|
|
Disease and Treatment-Related Morbidity in Young and Elderly Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis, file 188dce70-e04e-4a00-be75-597019f2e67c
|
2
|
|
Treatments for giant cell arteritis: Metaanalysis and assessment of estimates reliability using the fragility index, file 1b922e66-8719-4d6b-afa6-087f7d9dc5df
|
2
|
|
Erdheim-Chester disease, file 258b572f-76e3-42c0-83eb-098817cc3d4c
|
2
|
|
Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study, file 3a9f8ce0-3608-4724-9b52-dae6bf04ae6b
|
2
|
|
Chronic Rhinosinusitis in Eosinophilic Granulomatosis With Polyangiitis: Clinical Presentation and Antineutrophil Cytoplasmic Antibodies, file 3f46cb45-fadf-4021-b5b0-530ce620a66b
|
2
|
|
Update on the epidemiology, risk factors, and outcomes of systemic vasculitides, file 49334659-d38d-479d-8aa3-e421de001f70
|
2
|
|
Identification and phenotyping of circulating autoreactive proteinase 3-specific B cells in patients with PR3-ANCA associated vasculitis and healthy controls, file 5108d4c7-c5b0-4604-971a-f1b5eb34ecdf
|
2
|
|
Cardiovascular manifestations of Erdheim-Chester disease, file 5f9bc537-0edd-44c2-ae97-4c6c92080733
|
2
|
|
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management, file 639522bc-0de9-4b0c-b78c-e2fb219d4dbc
|
2
|
|
The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis, file 6fee4f29-1753-40e5-af68-69e73dca2f2c
|
2
|
|
Current and Future Treatment Options for Eosinophilic Granulomatosis With Polyangiitis, file 7060d9bb-b8fc-4e04-bd91-b3490aeec67a
|
2
|
|
Kaposi's Sarcoma in a Patient With Eosinophilic Granulomatosis With Polyangiitis While Taking Mycophenolate Mofetil, file 720bd380-a37f-4b35-bd8f-2d343f3e6512
|
2
|
|
Aortic thrombosis secondary to clopidogrel-related thrombotic
thrombocytopenic purpura, file 7a2e5333-dfb6-4509-850e-330c1f602f53
|
2
|
|
Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort, file 8879796c-c19c-4f7a-9d55-0c9584b24cdf
|
2
|
|
Orbital masses in ANCA-associated vasculitis: an unsolved challenge?, file 89ab0baa-2d8f-420a-a454-ffac901bed72
|
2
|
|
Eosinophilic granulomatosis with polyangiitis: the multifaceted spectrum of clinical manifestations at different stages of the disease, file 8d341e37-cceb-4a73-ba85-d63d2d3ba3a0
|
2
|
|
Health Literacy and Outcomes Among Patients With Heart Failure: A Systematic Review and Meta-Analysis, file 9bc481b7-5f72-49b5-8e45-6e47b649b302
|
2
|
|
Efficacy and safety of biological agents in adult-onset Still's disease, file 9c1f4eff-16dd-436b-b890-15d6d39c983f
|
2
|
|
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind
Placebo-Controlled Study, file aa912337-e254-406a-9563-53026d1bda58
|
2
|
|
EBV-induced lymphoproliferative disorders in rheumatic patients: A systematic review of the literature, file bfd2983d-de49-4fc2-ac17-a2df86ac446c
|
2
|
|
Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis., file c4315fae-d044-40e2-8ea2-b95e8d5a1c44
|
2
|
|
Proposal of a skin tests based approach for the prevention of recurrent hypersensitivity reactions to iodinated contrast media, file db4cabd6-80fd-45bf-b8eb-4241e2d5f2f5
|
2
|
|
The Severe Long-term Outcomes of “Non-severe” Eosinophilic Granulomatosis with Polyangiitis., file e4e0724c-a99a-4aa7-a119-c4c8adac2862
|
2
|
|
Interleukin-6 in ANCA-associated Vasculitis: Rationale for Successful Treatment With Tocilizumab, file ed9a401b-9a55-4468-8626-aa79fae49cd7
|
2
|
|
Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature, file f4f8625a-07d5-490e-960b-bc877a1b3e9c
|
2
|
|
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease, file f602afa5-627a-4589-b948-84d47dfe1aa1
|
2
|
|
Severe/uncontrolled Asthma and Overall Survival in Atopic Patients With Eosinophilic Granulomatosis With Polyangiitis, file fe204fde-e135-4a05-ab7e-8b4602533f8b
|
2
|
|
Juxta-vertebral lesions in granulomatosis with polyangiitis, file ff966eb2-5b09-4638-a459-cc9784dd904d
|
2
|
|
Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogénesis and disabling rebounds of proangiogenic myeloid cells, file 0c1faa32-65da-45dd-b37c-fbef126d6c49
|
1
|
|
Assessment Of Tocilizumab In The Treatment Of Cancer Cachexia, file 23bc3c80-c66e-4a99-84e9-ba3bf97f7396
|
1
|
|
Painful Fingers, file 371da0ec-43be-468e-b9c7-a5d7c98ea99f
|
1
|
|
Diagnosing Erdheim-Chester disease, file 38c1ee9a-3d59-40eb-b231-3a9bb0aeeb8b
|
1
|
|
The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US
Population-Based Study, file 3c495986-364d-4d46-83f1-beb6e885e5cc
|
1
|
|
Disease and Treatment-Related Morbidity in Young and Elderly Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis, file 3d67b643-3b20-4a3f-897f-07144e28fa32
|
1
|
|
Distinct Genetic Subsets in ANCA-associated Vasculitis, file 432fe372-e97f-4b8d-afaa-4b4775c5a893
|
1
|
|
Methotrexate in refractory bilateral juvenile temporal arteritis: Report of a case, file 46ff1eb0-b2e6-460d-be3a-9f0a59032599
|
1
|
|
Association of Smoking and Obesity on the Risk of Developing Primary Sjögren Syndrome: A Population-based Cohort Study, file 86ee19a8-4114-4be3-ad60-fa3e5abb0d92
|
1
|
|
Immunopatologia - Capitolo 80. Malattie allergiche, file b55b55d8-0b2f-4176-aa12-e570808eee71
|
1
|
|
The multifaceted clinical
presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature
and of 10 new cases, file d83f3c0e-3150-410a-bd6f-874decd74e31
|
1
|
|
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients, file e462fcb8-66ab-4410-a653-3ccc497734e2
|
1
|
| Totale |
270 |